Hypoglycemic and hypolipidemic effects of samnamul (shoot of Aruncus dioicus var. kamtschaticus Hara) in mice fed a high-fat/high-sucrose diet

被引:16
作者
Kim, Jung-In [1 ]
Yun, Jeong-A [1 ]
Jeong, Yoo-Kyung [1 ]
Baek, Hee-Jin [1 ]
机构
[1] Inje Univ, Sch Food & Life Sci, Dept Smart Foods & Drugs, 197 Inje Ro, Gimhae 50834, Gyeongsangnam D, South Korea
关键词
Aruncus dioicus var. kamtschaticus Hara; Glucose; Alpha-glucosidase; Triglyceride; Diabetes mellitus; INSULIN-RESISTANCE; ALPHA-GLUCOSIDASE; OXIDATIVE STRESS; INHIBITORY-ACTIVITIES; IN-VITRO; DYSLIPIDEMIA; ADIPONECTIN; MYRICETIN; ACARBOSE; OBESITY;
D O I
10.1007/s10068-018-0390-5
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The hypoglycemic and hypolipidemic effects of samnamul were investigated. The alpha-glucosidase inhibitory activity of samnamul in vivo was determined in normal mice. Oral administration of samnamul extract (500mg/kg) or acarbose (50mg/kg) significantly reduced the postprandial glucose response. The effects of chronic consumption of samnamul on fasting hyperglycemia and dyslipidemia were determined in C57BL/6J mice with diabetes mellitus induced by a high-fat/high-sucrose (HFHS) diet. Consumption of samnamul extract at 0.5% of the diet for 12weeks decreased serum glucose, triglyceride, and cholesterol levels, the homeostasis model assessment for insulin resistance index, and activities of maltase and sucrase in the small intestine. These results suggest that samnamul had hypoglycemic and hypolipidemic effects in an animal model of type 2 diabetes and that the hypoglycemic effect occurred partly via the inhibition of alpha-glucosidase activity.
引用
收藏
页码:1467 / 1473
页数:7
相关论文
共 38 条
[1]  
Ahn H, 2014, FOOD SCI BIOTECHNOL, V23, P1287
[2]   Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients [J].
Aleidi, Shereen ;
Issa, Ala ;
Bustanji, Haidar ;
Khalil, Mohammad ;
Bustanji, Yasser .
SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (03) :250-256
[3]  
Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37
[4]  
[Anonymous], 2017, CLIN DIABETES, DOI DOI 10.2337/CD16-0067
[5]   Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats [J].
Carrascosa, JM ;
Molero, JC ;
Fermín, Y ;
Martínez, C ;
Andrés, A ;
Satrústegui, J .
DIABETES OBESITY & METABOLISM, 2001, 3 (04) :240-248
[6]   Total radical-trapping antioxidant parameter in NIDDM patients [J].
Ceriello, A ;
Bortolotti, N ;
Falleti, E ;
Taboga, C ;
Tonutti, L ;
Crescentini, A ;
Motz, E ;
Lizzio, S ;
Russo, A ;
Bartoli, E .
DIABETES CARE, 1997, 20 (02) :194-197
[7]  
Ceriello A, 1996, DIABETOLOGIA, V39, P469, DOI 10.1007/BF00400679
[8]   Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494
[9]   Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet [J].
Choi, Ha-Neul ;
Kang, Min-Jung ;
Lee, Soo-Jin ;
Kim, Jung-In .
NUTRITION RESEARCH AND PRACTICE, 2014, 8 (05) :544-549
[10]   ASSAY OF INTESTINAL DISACCHARIDASES [J].
DAHLQVIST, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1984, 44 (02) :169-172